BRAF and thyroid gland carcinoma: The Cancer Genome Atlas Research Network has recently reported genomic, epigenomic, and proteomic profile differences between BRAF-like and RAS-like PTCs, which suggests a need to reclassify thyroid cancers into molecular subtypes [25].